使用JAK抑制剂托法替布治疗重度扁平苔藓。 - Suppr

Treatment of severe lichen planus with the JAK inhibitor tofacitinib.

作者信息

Damsky William, Wang Alice, Olamiju Brianna, Peterson Danielle, Galan Anjela, King Brett

机构信息

Department of Dermatology, Yale School of Medicine, New Haven, Conn.

Department of Dermatology, Yale School of Medicine, New Haven, Conn; Department of Pathology, Yale School of Medicine, New Haven, Conn.

出版信息

J Allergy Clin Immunol. 2020 Jun;145(6):1708-1710.e2. doi: 10.1016/j.jaci.2020.01.031. Epub 2020 Feb 1.

DOI:10.1016/j.jaci.2020.01.031

PMID:32018031

Abstract

摘要

相似文献

Treatment of severe lichen planus with the JAK inhibitor tofacitinib.

J Allergy Clin Immunol. 2020 Jun;145(6):1708-1710.e2. doi: 10.1016/j.jaci.2020.01.031. Epub 2020 Feb 1.

Treatment of lichen planopilaris with Janus kinase inhibitors.

Australas J Dermatol. 2024 Jun;65(4):381-383. doi: 10.1111/ajd.14240. Epub 2024 Feb 29.

Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia.

J Am Acad Dermatol. 2024 Jun;90(6):1260-1262. doi: 10.1016/j.jaad.2024.01.060. Epub 2024 Feb 2.

Novel Inhaled Pan-JAK Inhibitor, LAS194046, Reduces Allergen-Induced Airway Inflammation, Late Asthmatic Response, and pSTAT Activation in Brown Norway Rats.

J Pharmacol Exp Ther. 2019 Aug;370(2):137-147. doi: 10.1124/jpet.119.256263. Epub 2019 May 13.

The use of Tofacitinib in the treatment of inflammatory bowel disease.

Ter Arkh. 2019 Mar 18;91(2):101-108. doi: 10.26442/00403660.2019.02.000155.

The treatment of Tofacitinib for rosacea through the inhibition of the JAK/STAT signaling pathway.

Arch Dermatol Res. 2024 Aug 24;316(8):566. doi: 10.1007/s00403-024-03314-4.

Successful treatment of recalcitrant nodular prurigo with tofacitinib.

Clin Exp Dermatol. 2020 Oct;45(7):918-920. doi: 10.1111/ced.14320. Epub 2020 Jul 18.

The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease.

J Crohns Colitis. 2017 Jul 1;11(7):885-893. doi: 10.1093/ecco-jcc/jjx003.

Tofacitinib as Treatment for Nail Lichen Planus Associated With Alopecia Universalis.

JAMA Dermatol. 2021 Mar 1;157(3):352-353. doi: 10.1001/jamadermatol.2020.4555.

Tofacitinib Represses the Janus Kinase-Signal Transducer and Activators of Transcription Signalling Pathway in Keratinocytes.

Acta Derm Venereol. 2018 Aug 29;98(8):772-775. doi: 10.2340/00015555-2960.

引用本文的文献

Hydroxychloroquine is safe and efficacious in oral lichen planus: data from a large outpatient cohort.

Arch Dermatol Res. 2025 Apr 15;317(1):711. doi: 10.1007/s00403-025-04226-7.

Spatial Transcriptomics Reveals Differential Inflammatory Pathways in Discoid Lupus Erythematosus and Lichen Planus.

J Invest Dermatol. 2025 Sep;145(9):2344-2348.e7. doi: 10.1016/j.jid.2025.02.148. Epub 2025 Mar 18.

Therapy resistant hypertrophic lichen planus and its response to oral tofacitinib with a priori tissue cytokine expression: a real-world hospital-based study.

Arch Dermatol Res. 2025 Mar 17;317(1):590. doi: 10.1007/s00403-025-04088-z.

Erosive Lichen Planus Treated With Tofacitinib: A Case Series of 23 Patients.

Australas J Dermatol. 2025 Jun;66(4):234-237. doi: 10.1111/ajd.14452. Epub 2025 Mar 12.

Efficacy and Safety of Tofacitinib in Lichen Planopilaris: A Retrospective Series of 74 Patients.

Arch Iran Med. 2025 Jan 1;28(1):24-28. doi: 10.34172/aim.33237.

Diagnostic Difficulties of Erosive Lichen Planus in a Pediatric Patient.

Diagnostics (Basel). 2024 Dec 27;15(1):35. doi: 10.3390/diagnostics15010035.

Immune modules to guide diagnosis and personalized treatment of inflammatory skin diseases.

Nat Commun. 2024 Dec 18;15(1):10688. doi: 10.1038/s41467-024-54559-6.

Rapid response of lichen planus to baricitinib associated with suppression of cytotoxic CXCL13+CD8+ T cells.

J Clin Invest. 2024 Nov 14;135(2):e179436. doi: 10.1172/JCI179436.

Lichen Planus: What is New in Diagnosis and Treatment?

Am J Clin Dermatol. 2024 Sep;25(5):735-764. doi: 10.1007/s40257-024-00878-9. Epub 2024 Jul 9.

Remission of refractory esophageal lichen planus induced by tofacitinib.

Z Gastroenterol. 2024 Sep;62(9):1384-1388. doi: 10.1055/a-2300-0375. Epub 2024 Jun 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Treatment of severe lichen planus with the JAK inhibitor tofacitinib.

作者信息

Damsky William, Wang Alice, Olamiju Brianna, Peterson Danielle, Galan Anjela, King Brett

机构信息

Department of Dermatology, Yale School of Medicine, New Haven, Conn.

Department of Dermatology, Yale School of Medicine, New Haven, Conn; Department of Pathology, Yale School of Medicine, New Haven, Conn.

出版信息

J Allergy Clin Immunol. 2020 Jun;145(6):1708-1710.e2. doi: 10.1016/j.jaci.2020.01.031. Epub 2020 Feb 1.

DOI:10.1016/j.jaci.2020.01.031

PMID:32018031

Abstract

摘要

相似文献

Treatment of severe lichen planus with the JAK inhibitor tofacitinib.

J Allergy Clin Immunol. 2020 Jun;145(6):1708-1710.e2. doi: 10.1016/j.jaci.2020.01.031. Epub 2020 Feb 1.

Treatment of lichen planopilaris with Janus kinase inhibitors.

Australas J Dermatol. 2024 Jun;65(4):381-383. doi: 10.1111/ajd.14240. Epub 2024 Feb 29.

Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia.

J Am Acad Dermatol. 2024 Jun;90(6):1260-1262. doi: 10.1016/j.jaad.2024.01.060. Epub 2024 Feb 2.

Novel Inhaled Pan-JAK Inhibitor, LAS194046, Reduces Allergen-Induced Airway Inflammation, Late Asthmatic Response, and pSTAT Activation in Brown Norway Rats.

J Pharmacol Exp Ther. 2019 Aug;370(2):137-147. doi: 10.1124/jpet.119.256263. Epub 2019 May 13.

The use of Tofacitinib in the treatment of inflammatory bowel disease.

Ter Arkh. 2019 Mar 18;91(2):101-108. doi: 10.26442/00403660.2019.02.000155.

The treatment of Tofacitinib for rosacea through the inhibition of the JAK/STAT signaling pathway.

Arch Dermatol Res. 2024 Aug 24;316(8):566. doi: 10.1007/s00403-024-03314-4.

Successful treatment of recalcitrant nodular prurigo with tofacitinib.

Clin Exp Dermatol. 2020 Oct;45(7):918-920. doi: 10.1111/ced.14320. Epub 2020 Jul 18.

The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease.

J Crohns Colitis. 2017 Jul 1;11(7):885-893. doi: 10.1093/ecco-jcc/jjx003.

Tofacitinib as Treatment for Nail Lichen Planus Associated With Alopecia Universalis.

JAMA Dermatol. 2021 Mar 1;157(3):352-353. doi: 10.1001/jamadermatol.2020.4555.

Tofacitinib Represses the Janus Kinase-Signal Transducer and Activators of Transcription Signalling Pathway in Keratinocytes.

Acta Derm Venereol. 2018 Aug 29;98(8):772-775. doi: 10.2340/00015555-2960.

引用本文的文献

Hydroxychloroquine is safe and efficacious in oral lichen planus: data from a large outpatient cohort.

Arch Dermatol Res. 2025 Apr 15;317(1):711. doi: 10.1007/s00403-025-04226-7.

Spatial Transcriptomics Reveals Differential Inflammatory Pathways in Discoid Lupus Erythematosus and Lichen Planus.

J Invest Dermatol. 2025 Sep;145(9):2344-2348.e7. doi: 10.1016/j.jid.2025.02.148. Epub 2025 Mar 18.

Therapy resistant hypertrophic lichen planus and its response to oral tofacitinib with a priori tissue cytokine expression: a real-world hospital-based study.

Arch Dermatol Res. 2025 Mar 17;317(1):590. doi: 10.1007/s00403-025-04088-z.

Erosive Lichen Planus Treated With Tofacitinib: A Case Series of 23 Patients.

Australas J Dermatol. 2025 Jun;66(4):234-237. doi: 10.1111/ajd.14452. Epub 2025 Mar 12.

Efficacy and Safety of Tofacitinib in Lichen Planopilaris: A Retrospective Series of 74 Patients.

Arch Iran Med. 2025 Jan 1;28(1):24-28. doi: 10.34172/aim.33237.

Diagnostic Difficulties of Erosive Lichen Planus in a Pediatric Patient.

Diagnostics (Basel). 2024 Dec 27;15(1):35. doi: 10.3390/diagnostics15010035.

Immune modules to guide diagnosis and personalized treatment of inflammatory skin diseases.

Nat Commun. 2024 Dec 18;15(1):10688. doi: 10.1038/s41467-024-54559-6.

Rapid response of lichen planus to baricitinib associated with suppression of cytotoxic CXCL13+CD8+ T cells.

J Clin Invest. 2024 Nov 14;135(2):e179436. doi: 10.1172/JCI179436.

Lichen Planus: What is New in Diagnosis and Treatment?

Am J Clin Dermatol. 2024 Sep;25(5):735-764. doi: 10.1007/s40257-024-00878-9. Epub 2024 Jul 9.

Remission of refractory esophageal lichen planus induced by tofacitinib.

Z Gastroenterol. 2024 Sep;62(9):1384-1388. doi: 10.1055/a-2300-0375. Epub 2024 Jun 25.

Treatment of severe lichen planus with the JAK inhibitor tofacitinib.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Treatment of severe lichen planus with the JAK inhibitor tofacitinib.

作者信息

机构信息

出版信息

相似文献

引用本文的文献